Annual EBITDA:
-$56.03M-$1.87M(-3.45%)Summary
- As of today, MESO annual EBITDA is -$56.03 million, with the most recent change of -$1.87 million (-3.45%) on June 30, 2025.
- During the last 3 years, MESO annual EBITDA has risen by +$20.16 million (+26.46%).
- MESO annual EBITDA is now -4968.07% below its all-time high of -$1.11 million, reached on June 30, 2005.
Performance
MESO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
N/ASummary
- MESO quarterly EBITDA is not available.
Performance
MESO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM EBITDA:
N/ASummary
- MESO TTM EBITDA is not available.
Performance
MESO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MESO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -3.5% | - | - |
| 3Y3 Years | +26.5% | - | - |
| 5Y5 Years | +22.0% | - | - |
MESO EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -3.5% | +26.5% | ||||
| 5Y | 5-Year | -3.5% | +46.6% | ||||
| All-Time | All-Time | -4968.1% | +46.6% |
MESO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | -$56.03M(-3.4%) | - | - |
| Jun 2024 | -$54.16M(+21.1%) | - | - |
| Jun 2023 | -$68.69M(+9.8%) | - | - |
| Dec 2022 | - | -$18.74M(+26.0%) | -$18.74M(+26.0%) |
| Jun 2022 | -$76.19M(+27.4%) | - | - |
| Jun 2021 | -$104.90M(-46.0%) | - | - |
| Dec 2020 | - | -$25.32M(-9.0%) | -$25.32M(+2.9%) |
| Jun 2020 | -$71.83M(+8.8%) | - | - |
| Dec 2019 | - | -$23.23M(-721.2%) | -$26.06M(+2.0%) |
| Sep 2019 | - | -$2.83M(+88.1%) | -$26.58M(+68.9%) |
| Jun 2019 | -$78.73M(-6.8%) | - | - |
| Dec 2018 | - | -$23.75M(-45.2%) | -$85.53M(-21.2%) |
| Sep 2018 | - | -$16.36M(+27.9%) | -$70.56M(+4.3%) |
| Jun 2018 | -$73.72M(+17.2%) | -$22.70M(+0.1%) | -$73.72M(+0.4%) |
| Mar 2018 | - | -$22.72M(-158.7%) | -$74.02M(-1.4%) |
| Dec 2017 | - | -$8.78M(+55.0%) | -$73.01M(+15.8%) |
| Sep 2017 | - | -$19.52M(+15.1%) | -$86.74M(+2.5%) |
| Jun 2017 | -$88.98M | -$23.00M(-6.0%) | -$88.98M(-34.1%) |
| Mar 2017 | - | -$21.70M(+3.6%) | -$66.34M(-1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | - | -$22.51M(-3.4%) | -$65.33M(-0.5%) |
| Sep 2016 | - | -$21.76M(-5912.2%) | -$64.98M(-21.4%) |
| Jun 2016 | -$58.62M(+41.6%) | -$362.00K(+98.3%) | -$53.51M(+34.4%) |
| Mar 2016 | - | -$20.69M(+6.6%) | -$81.57M(-1.1%) |
| Dec 2015 | - | -$22.16M(-115.2%) | -$80.67M(+3.7%) |
| Sep 2015 | - | -$10.30M(+63.8%) | -$83.74M(-14.0%) |
| Jun 2015 | -$100.39M(-20.2%) | -$28.42M(-43.5%) | -$73.44M(-63.1%) |
| Mar 2015 | - | -$19.80M(+21.5%) | -$45.02M(-78.5%) |
| Dec 2014 | - | -$25.22M | -$25.22M |
| Jun 2014 | -$83.53M(-7.5%) | - | - |
| Jun 2013 | -$77.72M(-27.9%) | - | - |
| Jun 2012 | -$60.77M(-398.3%) | - | - |
| Jun 2011 | -$12.20M(-26.2%) | - | - |
| Jun 2010 | -$9.66M(-29.4%) | - | - |
| Jun 2009 | -$7.47M(+1.7%) | - | - |
| Jun 2008 | -$7.60M(-12.2%) | - | - |
| Jun 2007 | -$6.77M(-0.0%) | - | - |
| Jun 2006 | -$6.77M(-512.5%) | - | - |
| Jun 2005 | -$1.11M | - | - |
FAQ
- What is Mesoblast Limited annual EBITDA?
- What is the all-time high annual EBITDA for Mesoblast Limited?
- What is Mesoblast Limited annual EBITDA year-on-year change?
- What is the all-time high quarterly EBITDA for Mesoblast Limited?
- What is the all-time high TTM EBITDA for Mesoblast Limited?
What is Mesoblast Limited annual EBITDA?
The current annual EBITDA of MESO is -$56.03M
What is the all-time high annual EBITDA for Mesoblast Limited?
Mesoblast Limited all-time high annual EBITDA is -$1.11M
What is Mesoblast Limited annual EBITDA year-on-year change?
Over the past year, MESO annual EBITDA has changed by -$1.87M (-3.45%)
What is the all-time high quarterly EBITDA for Mesoblast Limited?
Mesoblast Limited all-time high quarterly EBITDA is -$362.00K
What is the all-time high TTM EBITDA for Mesoblast Limited?
Mesoblast Limited all-time high TTM EBITDA is -$18.74M